T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Chronic lymphocytic leukemia is characterized by impaired immune functions largely due to profound T-cell defects. T-cell functions also depend on co-signaling receptors, inhibitory or stimulatory, known as immune checkpoints, including cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and programmed death-1 (PD-1). Here we analyzed the T-cell phenotype focusing on immune checkpoints and activation markers in chronic lymphocytic leukemia patients (n=80) with different clinical characteristics and compared them to healthy controls. In general, patients had higher absolute numbers of CD3+ cells and the CD8+ subset was particularly expanded in previously treated patients. Progressive patients had higher numbers of CD4+ and CD8+ cells expressing PD-1 compared to healthy controls, which was more pronounced in previously treated patients (P=0.0003 and P=0.001, respectively). A significant increase in antigen-experienced T cells was observed in patients within both the CD4+ and CD8+ subsets, with a significantly higher PD-1 expression. Higher numbers of CD4+ and CD8+ cells with intracellular CTLA-4 were observed in patients, as well as high numbers of proliferating (Ki67+) and activated (CD69+) CD4+ and CD8+ cells, more pronounced in patients with active disease. The numbers of Th1, Th2, Th17 and regulatory T cells were substantially increased in patients compared to controls (P
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378 · cited 1×
“Upon binding to the ligands PD-L1 and PD-L2, PD-1 inhibits T-cell functions reducing T-cell receptor signaling and target cell lysis.(10) Except for cells of the macrophage lineage, PD-L1 has low expression in normal tissues; on the other hand, it is highly expressed on various tumors and can be further enhanced by tu…”
BackgroundTumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 1×
“The PD-1/PD-L1 pathway is considered a central regulator of T-cell exhaustion, a condition characterized by deteriorated Tcell effector function due to chronic antigen stimulation.(13) Tumor cells as well as pathogens exploit these inhibitory signals to hamper immune eradication.”
BackgroundUnmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
Hamblin, T. J., Davis, Z., Gardiner, A., Oscier, D. G., & Stevenson, F. K. (1999) · Blood · doi:10.1182/blood.v94.6.1848 · Cited by 2,783
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 1×
“Tregs were defined by the expression of CD4, CD25 and CCR4 and CD127.(22,23) Both non-progressive and progressive untreated CLL patients had higher numbers of Th1 cells compared to controls (median 406 and 1064 vs.”
BackgroundSeddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Tregs were defined by the expression of CD4, CD25 and CCR4 and CD127.(22,23) Both non-progressive and progressive untreated CLL patients had higher numbers of Th1 cells compared to controls (median 406 and 1064 vs.”
BackgroundBlockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314 · cited 1×
“Except for cells of the macrophage lineage, PD-L1 has low expression in normal tissues; on the other hand, it is highly expressed on various tumors and can be further enhanced by tumor environmental factors.(11,12) The PD-1/PD-L1 pathway is considered a central regulator of T-cell exhaustion, a condition characterized…”
BackgroundLundin, J., Porwit-MacDonald, A., Rossmann, E. D., Karlsson, C., Edman, P., Rezvany, M. R., Kimby, E., Österborg, A., & Mellstedt, H. (2004) · Leukemia · doi:10.1038/sj.leu.2403258 · Cited by 118 · cited 1×
“We tried to define more specifically the impact of different treatment regimens on T-cell phenotype by further subgrouping the patients into those who had received alemtuzumab and those who had received fludarabine/cyclophosphamide, since these drugs have a known effect on T cells.(46,47) The number of Th1 cells was s…”
MethodSelf-citation
Cited by
Mechanisms of T cell exhaustion guiding next-generation immunotherapy
Zebley, C. C., & Youngblood, B. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.04.004 · Cited by 65
Mhibik, M., Gaglione, E. M., Eik, D., Kendall, E. K., Blackburn, A., Keyvanfar, K., Baptista, M. J., Ahn, I. E., Sun, C., Qi, J., et al. (2021) · Blood · doi:10.1182/blood.2020009686 · Cited by 30
Metadata
- Authors
- Palma, M., Gentilcore, G., Heimersson, K., Mozaffari, F., Näsman-Glaser, B., Young, E., Rosenquist, R., Hansson, L., Österborg, A., & Mellstedt, H.
- Venue
- Haematologica
- Published
- 2016-12-07
- Volume
- 102
- Issue
- 3
- Pages
- 562-572
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2560661681
- Cited by
- 163
- References
- 8
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. https://app.cochat.ai/papers/10.3324/haematol.2016.151100
- The paper
- Palma, M., Gentilcore, G., Heimersson, K., Mozaffari, F., Näsman-Glaser, B., Young, E., Rosenquist, R., Hansson, L., Österborg, A., & Mellstedt, H. (2017). T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers. Haematologica. https://doi.org/10.3324/haematol.2016.151100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.